|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Chemistry, Syracuse University, Syracuse, New York (C.R.C., K.A.T., D.J.K., J.G., J.C.D.); and Department of Pediatrics, Upstate Medical University, State University of New York, Syracuse, New York (B.B.T., R.L.D.)
The interactions of Jurkat cells with cisplatin, cis-[Pt(15NH3)2Cl2](1), are studied using 1H-15N heteronuclear single quantum coherence (HSQC) NMR and inductively coupled plasma mass spectrometry. We show that Jurkat cells in culture rapidly modify the monocarbonato complex cis-[Pt(15NH3)2(CO3)Cl]- (4), a cisplatin species that forms in culture media and probably also in blood. Analysis of the HSQC NMR peak intensity for 4 in the presence of different numbers of Jurkat cells reveals that each cell is capable of modifying 0.0028 pmol of 4 within
0.6 h. The amounts of platinum taken up by the cell, weakly bound to the cell surface, remaining in the culture medium, and bound to genomic DNA were measured as functions of time of exposure to different concentrations of drug. The results show that most of the 4 that has been modified by the cells remains in the culture medium as a substance of molecular mass <3 kDa, which is HSQC NMR silent, and is not taken up by the cell. These results are consistent with a hitherto undocumented extracellular detoxification mechanism in which the cells rapidly modify 4, which is present in the culture medium, so it cannot bind to the cell. Because there is only a slow decrease in the amount of unmodified 4 remaining in the culture medium after 1 h, -1.1 ± 0.4 µM h-1, the cells subsequently lose their ability to modify 4. These observations have important implications for the mechanism of action of cisplatin.
Received for publication February 2, 2006.
Accepted for publication April 19, 2006.
Address correspondence to: Dr. James C. Dabrowiak, Department of Chemistry, 111 College Place, Rm. 1-014 CST, Syracuse University, Syracuse, NY 13244-4100. E-mail: jcdabrow{at}syr.edu
This article has been cited by other articles:
![]() |
R. N. Bose, L. Maurmann, R. J. Mishur, L. Yasui, S. Gupta, W. S. Grayburn, H. Hofstetter, and T. Salley Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells PNAS, November 25, 2008; 105(47): 18314 - 18319. [Abstract] [Full Text] [PDF] |
||||